More Consolidation in the Clinical Laboratory Industry, as Quest Diagnostics Agrees to Pay $570 Million to Acquire Solstas Lab Partners

When completed, this acquisition will give Quest Diagnostics a major laboratory presence in the backyard of competitor Laboratory Corporation of America Another big lab domino fell in the continuing consolidation of the clinical laboratory testing industry. This time it was Solstas Lab Partners, which announced that it would be acquired by Quest Diagnostics Incorporated (NYSE:DGX). The agreement was announced by both companies earlier this week. Quest Diagnostics will pay $570 million to...

Prior to IPO Pathology Company Aurora Diagnostics Gets New $335 Million Credit Line

Anatomic pathology firm hopes proposed sale of stock will bring in up to $150 million Anatomic pathology company Aurora Diagnostics, Inc., of Palm Beach Gardens, Florida, just announced a new credit facility that will give it access to as much as $335 million should all conditions be met. Aurora Diagnostics hopes to raise $150 million from an initial public offering (IPO) of its stock, for which it filed registration documents in April. Aurora Diagnostics was founded in June 2006, by former...

Merger of Spectrum Laboratory Network and Carilion Labs Creates Big Clinical Laboratory Company

Carilion Clinic and Novant Health will continue to own equity in the new clinical laboratory company It was big news in the clinical laboratory industry yesterday when Spectrum Laboratory Network of Greensboro, North Carolina announced a merger with Carilion Labs of Roanoke, Virginia. The combined enterprise will have annual revenue of approximately $300 million and immediately becomes one of the nation’s larger clinical laboratory companies. As announced by the parties involved, Carilion...

Spectrum Laboratory Network Sells to Welsh Carson for $230 Million

Acquisition is a deal between two private equity firms Spectrum Laboratory Network of Greensboro, North Carolina, will be acquired by Welsh, Carson, Anderson, & Stowe. Investment funds managed by Apax Partners are the sellers and the purchase price is $230 million. It is the highest dollar value acquisition of a clinical laboratory during 2009. The acquisition agreement was announced at the end of last week. It brings Welsh, Carson back into the laboratory testing industry for the first...

James Peter, M.D., Ph.D., Founder of Specialty Laboratories, Dies of Cancer

Peter Built His Company into a Major National Esoteric Laboratory One of laboratory medicine’s most successful scientist-entrepreneurs died last Friday, October 30, 2009. James B. Peter M.D., Ph.D., Founder of Specialty Laboratories, Inc., died in his home in Santa Monica, California of complications from cancer. He was 76 years old. A native of Omaha, Nebraska, it was 1958 when Peter earned his M.D. from St. Louis University. He then went to the University of Minnesota where he earned a Ph.D....
;